Justin Paquette
Neurological Surgery · Sacramento, CANPI 1154358661
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $15,743 of the $17,419 with a category attached, or 90.4%. 12 manufacturers reported payments, led by Alphatec Spine, Inc at 55.3% of the total. Reporting peaked in 2020 at $5,344 and has fallen 99.8% since, to $13 in 2025.
Across 65 payments — averaging $267.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$10K
- Globus Medical$6K
- Zimmer Biomet$690
- Nexxt Spine LLC$399
- Kahtnu Surgical, Inc.$287
- Arteriocyte Medical Systems, Inc.$109
- plus $192 from 6 others
What the payments were for
- Royalty or licence$15,74390%
- Food & beverage$1,67610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 15 | $9,631 |
| Globus Medical | 16 | $6,112 |
| Zimmer Biomet | 20 | $690 |
| Nexxt Spine LLC | 3 | $399 |
| Kahtnu Surgical, Inc. | 2 | $287 |
| Arteriocyte Medical Systems, Inc. | 1 | $109 |
| Spinesmith Holdings, LLC | 3 | $77 |
| Wenzel Spine, Inc. | 1 | $41 |
| Baxter Healthcare | 1 | $29 |
| Abbott | 1 | $17 |
| Nevro Corp. | 1 | $15 |
| Neo Spine USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OsseoScrew$9,507
- INTERCONTINENTAL$5,354
- InterContinental /Trans M$758
- Talkeetna, Kasilof, CHENA-C$243
- Magellan$109
- Influx$109
- Polaris S.S. Spinal System$101
- Trabecular Metal (TM)$101
How this compares
$17,419 in reported general payments places this provider in the 70th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $318 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $301 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $149 |
| Cyclobenzaprine Hcl | 18 | $139 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Sacramento
- Kee KimSacramento$682K
- Ben WaldauSacramento$207K
- Christopher AmesSan Francisco$7.1M
- Larry KhooLos Angeles$2.8M
- Samy AbdouSan Diego$2.4M
- Bret AbshireMurrieta$2.3M
- William TaylorSan Diego$2.1M
- Tooraj GravoriEncino$2M
- Ali MesiwalaRancho Cucamonga$1.5M
- Joseph OsorioSan Diego$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.